TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/25 16:02 | 2/28/25 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Kalif Eliyahu Sharon | L3 | O | EVP,CFO | S.d | -903 | 16.21 | 0 | -56 | -22 | 198 | D | ||||||||||||||
3/7/24 16:27 | 3/6/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Kalif Eliyahu Sharon | L3 | O | EVP,CFO | S.d | -1,048 | 13.52 | 0 | -78 | -28 | 204 | D | ||||||||||||||
8/9/23 16:02 | 8/7/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Kalif Eliyahu Sharon | L3 | O | EVP,CFO | S | -342 | 9.73 | 0 | -35 | -26 | 99 | D | ||||||||||||||
8/24/22 07:50 | 8/22/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Kalif Eliyahu Sharon | L3 | O | EVP,CFO | S | -559 | 10.07 | 0 | -56 | -86 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |